Pharmaceutical

Lyell goes all in on CAR-T therapies, buys ImmPACT Bio and trims pipeline

The California-based Lyell is expected to pay up to $30m in cash along with shares and milestone-based payments.

Oct 26, 2024 - 04:00
Lyell goes all in on CAR-T therapies, buys ImmPACT Bio and trims pipeline
The California-based Lyell is expected to pay up to $30m in cash along with shares and milestone-based payments.
Read the original article

Tags:

Previous Article

GSK pumps up to $800m for US manufacturing site upgrade

Next Article

Sanofi-backed Agomab raises $89m to advance fibrotic disease treatments

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: A Q&A with Vertex founder Joshua Boger on Casgevy, the biotech industry, and Elon Musk

STAT+: A Q&A with Vertex founder Joshua Boger on Casgev...

Dec 11, 2023

STAT+: Biden administration goes easy on Medicare Advantage insurers after intense industry lobbying

STAT+: Biden administration goes easy on Medicare Advan...

Apr 1, 2023

Launching pharmaceuticals in the Nordics: Opportunities and challenges

Launching pharmaceuticals in the Nordics: Opportunities...

Sep 5, 2023